Cha Boram, Park Jin-Seok, Jeong Seok, Lee Don Haeng, Cho Jae Hee
Division of Gastroenterology, Department of Internal Medicine, Inha University School of Medicine, Incheon, South Korea.
National Center of Efficacy Evaluation for the Development of Health Products Targeting Digestive Disorders (NCEED), Incheon, South Korea.
J Invest Surg. 2022 Feb;35(2):243-248. doi: 10.1080/08941939.2020.1839148. Epub 2020 Nov 4.
Side-by-side (SBS) bilateral placement of self-expandable metal stents (SEMSs) is limited by technical difficulties in cases of malignant hilar bile duct obstruction (MHBO). Recently, a braided SEMS with a 5.9 F ultra-thin introducer was developed that enables simultaneous bilateral stenting. This preliminary study was undertaken to determine the feasibility, safety, and effectiveness of SBS simultaneous bilateral stenting using braided SEMSs and a 5.9 F introducer for MHBO management. We reviewed 8 patients of medical reports who were performed simultaneous SBS placement of SEMSs due to MHBO between January 2016 and January 2018. Both of technical and clinical success rates were 100% (8/8), and success rate of stent distal end alignment was also 100%. None of early procedure-related adverse events were detected in 30 days after the stent insertion. Median duration of stent patency was 300 days (95% Cl, 280-726.9), and median survival was 229 days (range, 128-728). Simultaneous SBS stent placement using novel braided metal stents was found to be feasible in patients with MHBO. Prospective well-designed clinical studies are needed to certify the efficacy of the stenting technique for MHBO.
在恶性肝门部胆管梗阻(MHBO)病例中,自膨式金属支架(SEMS)的并排(SBS)双侧放置受到技术难题的限制。最近,一种带有5.9F超薄导入器的编织SEMS被研发出来,可实现双侧同时支架置入。本初步研究旨在确定使用编织SEMS和5.9F导入器进行SBS双侧同时支架置入以治疗MHBO的可行性、安全性和有效性。我们回顾了2016年1月至2018年1月期间因MHBO接受SEMS的SBS双侧同时置入的8例患者的医学报告。技术成功率和临床成功率均为100%(8/8),支架远端对齐成功率也为100%。在支架置入后30天内未检测到任何早期手术相关不良事件。支架通畅的中位持续时间为300天(95%Cl,280 - 726.9),中位生存期为229天(范围,128 - 728)。发现使用新型编织金属支架进行SBS双侧同时支架置入对MHBO患者是可行的。需要进行前瞻性精心设计的临床研究来证实该支架置入技术对MHBO的疗效。